| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1995PNAS...92.4517K |
| P356 | DOI | 10.1073/PNAS.92.10.4517 |
| P932 | PMC publication ID | 41975 |
| P698 | PubMed publication ID | 7753836 |
| P5875 | ResearchGate publication ID | 15445028 |
| P2093 | author name string | Akiyama T | |
| Toyoshima K | |||
| Moriyama M | |||
| Kudoh T | |||
| Ishidate T | |||
| P2860 | cites work | WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. | Q38302906 |
| The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma | Q38317044 | ||
| Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence | Q38338176 | ||
| WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. | Q41508164 | ||
| Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. | Q41508377 | ||
| Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome | Q41660674 | ||
| Transcriptional repression mediated by the WT1 Wilms tumor gene product | Q41661461 | ||
| Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen | Q48084448 | ||
| Expression of the Wilms' tumor gene (WT1) in human leukemias | Q53490672 | ||
| Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript | Q59662123 | ||
| Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1 | Q67493857 | ||
| Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals | Q24314293 | ||
| p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest | Q24319021 | ||
| The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases | Q24319848 | ||
| Cloning of a human gene, PIG-F, a component of glycosylphosphatidylinositol anchor biosynthesis, by a novel expression cloning strategy | Q24323432 | ||
| Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1 | Q24337538 | ||
| Zinc finger point mutations within the WT1 gene in Wilms tumor patients | Q24561664 | ||
| Rapid and efficient site-specific mutagenesis without phenotypic selection | Q27860608 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
| Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
| A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase | Q28247022 | ||
| A cyclin associated with the CDK-activating kinase MO15 | Q28247696 | ||
| p21 is a universal inhibitor of cyclin kinases | Q28257305 | ||
| p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 | Q28505037 | ||
| WT-1 is required for early kidney development | Q28512266 | ||
| D-type cyclin-dependent kinase activity in mammalian cells | Q29614966 | ||
| G1 phase progression: cycling on cue | Q29615162 | ||
| Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age | Q29618409 | ||
| An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor | Q34189532 | ||
| The candidate Wilms' tumour gene is involved in genitourinary development | Q34189819 | ||
| Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase | Q36669326 | ||
| Phosphorylation of the retinoblastoma protein by cdk2 | Q37169903 | ||
| Alternative splicing and genomic structure of the Wilms tumor gene WT1 | Q37611742 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nephroblastoma | Q756289 |
| P304 | page(s) | 4517-4521 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes | |
| P478 | volume | 92 |
| Q42830606 | A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1. |
| Q24324095 | A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1 |
| Q52974188 | Analysis of Wilms tumor gene (WT1) expression in acute leukemia patients with special reference to the differential diagnosis between eosinophilic leukemia and idiopathic hypereosinophilic syndromes. |
| Q30530827 | Asbestos and mesothelioma: genetic lessons from a tragedy |
| Q24303633 | BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1 |
| Q42049050 | Cell cycle regulation and differentiation in the human podocyte lineage |
| Q44092524 | Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour |
| Q24309269 | Ciao 1 is a novel WD40 protein that interacts with the tumor suppressor protein WT1 |
| Q42817131 | Cyclin E is a target of WT1 transcriptional repression |
| Q40716988 | Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation |
| Q36569185 | Expression and function of the leucine zipper protein Par-4 in apoptosis |
| Q34551202 | Expression of inhibin-alpha is regulated synergistically by Wilms' tumor gene 1 (Wt1) and steroidogenic factor-1 (Sf1) in sertoli cells |
| Q34438119 | Genetic predisposition to cancer and familial cancer syndromes |
| Q22003911 | Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition |
| Q24308507 | Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70 |
| Q40937124 | Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties |
| Q33723073 | Lipoplexes and tumours. A review |
| Q34378971 | MCC, a cytoplasmic protein that blocks cell cycle progression from the G0/G1 to S phase |
| Q24322684 | Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9 |
| Q74615935 | Novel growth factor supporting survival of murine primordial germ cells: evidence from conditioned medium of ter fetal gonadal somatic cells |
| Q40728596 | Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene |
| Q41157249 | Suppression of fibroblast cell growth by overexpression of LIM-kinase 1. |
| Q42800235 | The Wilms tumor protein is persistently associated with the nuclear matrix throughout the cell cycle |
| Q34077533 | The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells |
| Q57942684 | The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells |
| Q41663756 | The Wilms tumour gene WT1 in leukaemia |
| Q24310213 | The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase |
| Q41625163 | Tumor suppressor genes and human cancer |
| Q33786522 | Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding |
| Q38325277 | Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control |
| Q34293053 | Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma |
| Q34820008 | Wilms tumor gene (WT1) expression as a panleukemic marker |
| Q40114088 | Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation |
| Q36234726 | Wilms' tumour: connecting tumorigenesis and organ development in the kidney |
Search more.